Table 3 Characteristics of therapeutic procedures.
| Variable | Jaundice N=302 | Variable | GOO N=21 |
| AE, adverse event; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; CDS, choledochoduodenostomy; GOO, gastric outlet obstruction; GBD, gallbladder drainage; GE, gastro-enterostomy; HGS, hepaticogastrostomy; IQR, interquartile range; LAMS, lumen apposing metal stent; PTBD, percutaneous transhepatic biliary drainage. * Sum of times for the diagnostic part, patient repositioning and instrument exchange, and the therapeutic part. | |||
| Endoscopic technical success, n (%) | 294 (97.4) | 20 (95.2) | |
| ERCP | 251 (83.1) | EUS-GE | 15 (71.4) |
| EUS-CDS | 37 (12.3) | Enteral Stenting | 6 (28.6) |
| EUS-HGS | 5 (1.7) | ||
| EUS-GBD | 1 (0.3) | ||
| Rescue of endoscopic failure, n (%) | |||
| PTBD | 7 (2.3) | ||
| Surgery | 1 (0.3) | Surgery | 1 (4.8) |
| AEs n (%) | 38 (12.6) | 3 (14.3) | |
| Post-ERCP acute pancreatitis | 17 (5.6) | ||
| Cholecystitis | 11 (3.6) | ||
| Cholangitis | 4 (1.3) | ||
| Bleeding | 5 (1.7) | Bleeding | 1 (4.8) |
| LAMS misdeployment | 1 (0.3) | LAMS misdeployment | 1 (4.8) |
| Vomiting | 1 (4.8) | ||
| Procedure time * [IQR], minutes | 90 [69.3–109.5] | 101 [84.3–107.5] | |
| Hospital stay [IQR], days | 3 [2–7] | 6.5 [4.5–11] | |
| Time to CHT [IQR], days | 34 [25–49] | 26.5 [20–28] | |